Munc13-1 is a key protein necessary for vesicle fusion
and neurotransmitter
release in the brain. Diacylglycerol (DAG)/phorbol ester binds to
its C1 domain in the plasma membrane and activates it. The C1 domain
of Munc13-1 and protein kinase C (PKC) are homologous in terms of
sequence and structure. In order to identify small-molecule modulators
of Munc13-1 targeting the C1 domain, we studied the effect of three
DAG-lactones, (R,Z)-(2-(hydroxymethyl)-4-(3-isobutyl-5-methylhexylidene)-5-oxotetrahydrofuran-2-yl)methyl
pivalate (JH-131e-153), (E)-(2-(hydroxymethyl)-4-(3-isobutyl-5-methylhexylidene)-5-oxotetrahydrofuran-2-yl)methyl
pivalate (AJH-836), and (E)-(2-(hydroxymethyl)-4-(4-nitrobenzylidene)-5-oxotetrahydrofuran-2-yl)methyl
4-(dimethylamino)benzoate (130C037), on Munc13-1 activation using
the ligand-induced membrane translocation assay. JH-131e-153 showed
higher activation than AJH-836, and 130C037 was not able to activate
Munc13-1. To understand the role of the ligand-binding site residues
in the activation process, three alanine mutants were generated. For
AJH-836, the order of activation was wild-type (WT) Munc13-1 >
R592A
> W588A > I590A. For JH-131e-153, the order of activation was
WT >
I590 ≈ R592A ≈ W588A. Overall, the Z isomer of DAG-lactones showed higher potency than the E isomer and Trp-588, Ile-590, and Arg-592 were important for its
binding. When comparing the activation of Munc13-1 and PKC, the order
of activation for JH-131e-153 was PKCα > Munc13-1 > PKCε
and for AJH-836, the order of activation was PKCε > PKCα
> Munc13-1. Molecular docking supported higher binding of JH-131e-153
than AJH-836 with the Munc13-1 C1 domain. Our results suggest that
DAG-lactones have the potential to modulate neuronal processes via
Munc13-1 and can be further developed for therapeutic intervention
for neurodegenerative diseases.